The iFuse Bedrock Granite implant is designed for sacroiliac fusion and sacropelvic fixation and received the FDA’s breakthrough device designation, according to an April 19 news release.
Approval for the payment is subject to FDA clearance and finalization of the proposed rule. The CMS payment will help widen access to Medicare patients.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
